Your browser doesn't support javascript.
loading
Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project.
Boada, Mercè; Rodrigo, Adrián; Jessen, Frank; Wimblad, Bengt; Kramberger, Milica G; Visser, Pieter Jelle; Simó, Rafael; Rodríguez-Gomez, Octavio; Ciudin, Andreea; Georges, Jean; Dumas, Annete; Maguire, Peggy; Krivec, David; Wimo, Anders; Valero, Sergi; Alegret, Montserrat; Jamilis, Laura; Zwan, Marissa; Sannemann, Lena; Arrufat, Jordi; Stomrud, Erik; Johansson, Gunilla; Shering, Craig; Glaysher, Bridget; Stewart, Neil; Belger, Mark; Iradier, Fatima; Campo, Laura.
Afiliación
  • Boada M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.
  • Rodrigo A; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain.
  • Jessen F; GMV SECURE E SOLUTIONS, Valencia, Spain.
  • Wimblad B; Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Kramberger MG; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Visser PJ; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
  • Simó R; Theme Aging, Karolinska Univ Hospital, Stockholm, Sweden.
  • Rodríguez-Gomez O; Department of Neurology, University Medical Center Ljubljana and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Ciudin A; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Georges J; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Dumas A; Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.
  • Maguire P; CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain.
  • Krivec D; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.
  • Wimo A; Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.
  • Valero S; CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain.
  • Alegret M; Alzheimer Europe, Luxembourg.
  • Jamilis L; ASDM Consulting, Brussels, Belgium.
  • Zwan M; European Institute of Women's Health, Dublin, Ireland.
  • Sannemann L; Zdruzenje Spomincica, Ljubljana, Slovenia.
  • Arrufat J; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
  • Stomrud E; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.
  • Johansson G; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain.
  • Shering C; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.
  • Glaysher B; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain.
  • Stewart N; GMV SECURE E SOLUTIONS, Valencia, Spain.
  • Belger M; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Iradier F; Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Campo L; EAP Sarrià-Vallvidrera-Les Planes, Barcelona, Spain.
Alzheimers Dement ; 18(6): 1119-1127, 2022 06.
Article en En | MEDLINE | ID: mdl-34310061

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Demencia / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Demencia / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos